Nasdaq nmra.

Atomera Inc (NASDAQ:ATOM)’s traded shares stood at 0.16 million during the last session, with the company’s beta value hitting 1.45. At the close of trading, the stock’s price was $6.97, to imply an increase of 0.29% or $0.02 in intraday trading. The ATOM share’s 52-week high remains $10.72 ...Navacaprant is an investigational once-daily oral medication that is designed to modulate the dopamine and reward processing pathways. Its other product candidates include NMRA-511, NMRA-266, NMRA-NMDA, NMRA-CK1d, NMRA-NLRP3, and NMRA-GCase. NMRA-511 is an investigational antagonist of the vasopressin 1a receptor (V1aR).NASDAQ: NMRA · IEX Real-Time Price · USD. Add to Watchlist 11.92 +0.01 (0.08%) Nov 24, 2023, 4:30 PM EST - Market closed. Overview; Financials; ... Stock Price Forecast. According to 5 stock analysts, the average 12-month stock price forecast for NMRA stock stock is $22, which predicts an increase of 84.56%. The lowest target is $18 …Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) shares gapped up before the market opened on Wednesday .The stock had previously closed at $11.69, but opened at $12.14. Neumora ...

Neumora Therapeutics Inc. Common Stock stock price (NMRA) NASDAQ: NMRA. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Neumora Therapeutics Inc. Common Stock stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.

CGC. Canopy Growth Corporation Common Shares. $1.275 -0.065 -4.85%. Find the latest SEC Filings data for Neumora Therapeutics, Inc. Common Stock (NMRA) at Nasdaq.com.

The Watertown, MA-based Neumora Therapeutics ( NASDAQ: NMRA ), a Phase 3 biotech developing therapies for brain diseases has priced its initial public offering of 14.71 million shares of its ...Its other product candidates include NMRA-511, NMRA-266, NMRA-NMDA, NMRA-CK1d, NMRA-NLRP3, and NMRA-GCase. NMRA-511 is an investigational antagonist of the vasopressin 1a receptor (V1aR). NMRA-266 is a positive allosteric modulator of the M4 muscarinic receptor (M4R) for the treatment of schizophrenia and other neuropsychiatric …Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) shares gapped up before the market opened on Wednesday .The stock had previously closed at $11.69, but opened at $12.14. Neumora ...The latest price target for CymaBay Therapeutics ( NASDAQ: CBAY) was reported by Cantor Fitzgerald on Wednesday, November 8, 2023. The analyst firm set a price target for 24.00 expecting CBAY to ...

Neumora Therapeutics, Inc. (NASDAQ:NMRA) as filed to raise $100 million in an IPO of its common stock, according to an SEC S-1 registration statement.

Ventyx Biosciences, Inc. (NASDAQ:VTYX) fell 22.1% to $23.38 after the company announced results from the Phase 2 trial of VTX002 in patients with moderate-to-severely active ulcerative colitis.

NASDAQ: NMRA. Membeli atau menjual saham yang tidak diperdagangkan dalam mata uang lokal Anda? Jangan biarkan konversi mata uang membuat Anda rugi. Konversi saham atau unit saham Neumora Therapeutics Inc. Common Stock ke mata uang apa pun dengan alat praktis kami, dan Anda akan selalu tahu apa yang Anda dapatkan.Veja o histórico completo das cotações para Neumora Therapeutics Inc, consulte informações sobre o preço de fechamento, de abertura, máximas, mínimas e as …Shares of Neumora Therapeutics (NMRA 0.41%) were down more than 32% for the week as of Thursday's market close, according to data provided by S&P Global Market Intelligence.Canopy Growth Corporation Common Shares. $1.275 -0.065 -4.85%. Neumora Therapeutics, Inc. Common Stock (NMRA) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US ...$8.11 +0.06 +0.75% Find the latest Financials data for Neumora Therapeutics, Inc. Common Stock (NMRA) at Nasdaq.com.Nov 1, 2023 · Successfully completed initial public offering: In September 2023, Neumora completed its initial public offering of its common stock and shares began trading on the Nasdaq Global Select Market under the ticker symbol “NMRA.” Since its inception, Neumora has raised over $850 million to further its mission to confront the global brain disease ...

It plans to list on the Nasdaq under the ticker symbol "NMRA." J.P. Morgan, BofA Securities, Stifel, Guggenheim Securities, RBC Capital Markets and William Blair are backing the listing. Neumora ...Neumora Therapeutics Inc. Common Stock stock price (NMRA) NASDAQ: NMRA. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Neumora Therapeutics Inc. Common Stock stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.Nov 24, 2023 · A. The latest price target for Tilray Brands ( NASDAQ: TLRY) was reported by Roth MKM on Friday, September 1, 2023. The analyst firm set a price target for 2.50 expecting TLRY to rise to within 12 ... NMRA-266 is an investigational positive allosteric modulator of the M4 muscarinic receptor subtype, a clinically validated target for the treatment of schizophrenia. Neumora exclusively licensed ...4 hari yang lalu ... Moleculin Biotech (NASDAQ:MBRX) stock is jumping more than 15% without any clear news today. Neumora Therapeutics (NASDAQ:NMRA) shares are up ...

WATERTOWN, Mass., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug ...Encontre o valor de abertura e fechamento das cotações NMRA para ficar atualizado sobre as tendências do mercado financeiro. Compartilhe sua visão de mercado, interaja com …

WATERTOWN, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced financial results for the third quarter ended September 30, 2023 and provided ... (NMRA-140) is a highly selective, novel, …Nov 1, 2023 · Successfully completed initial public offering: In September 2023, Neumora completed its initial public offering of its common stock and shares began trading on the Nasdaq Global Select Market under the ticker symbol “NMRA.” Since its inception, Neumora has raised over $850 million to further its mission to confront the global brain disease ... Neumora Therapeutics, Inc. Common Stock stock price (NMRA) NASDAQ: NMRA. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Neumora Therapeutics, Inc. Common Stock stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.WATERTOWN, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced ...Find the latest Financials data for Neumora Therapeutics, Inc. Common Stock (NMRA) at Nasdaq.com.The latest price target for . Neumora Therapeutics (NASDAQ: NMRA) was reported by JP Morgan on November 8, 2023.The analyst firm set a price target for $20.00 expecting NMRA to rise to within 12 ... Based on analysts offering 12 month price targets for NMRA in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .The latest Neumora Therapeutics stock prices, stock quotes, news, and NMRA history to help you invest and trade smarter ... Nasdaq Live · World Map · The word ...Sep 21, 2023 · Shares of Neumora Therapeutics (NMRA 0.41%) were down more than 32% for the week as of Thursday's market close, according to data provided by S&P Global Market Intelligence.

The latest price target for Neumora Therapeutics ( NASDAQ: NMRA) was reported by JP Morgan on Tuesday, October 10, 2023. The analyst firm set a price target for 21.00 expecting NMRA to rise to ...

Sep 15, 2023 · Find the latest Earnings Report Date for Neumora Therapeutics, Inc. Common Stock (NMRA) at Nasdaq.com.

NASDAQ: NMRA · IEX Real-Time Price · USD. Add to Watchlist 12.33 +0.08 (0.65%) Dec 1, 2023, 4:30 PM EST - Market closed. Overview; Financials; ... Stock Price Forecast. According to 5 stock analysts, the average 12-month stock price forecast for NMRA stock stock is $22, which predicts an increase of 78.43%. The lowest target is $18 …Neumora Therapeutics, Inc. (NASDAQ:NMRA – Free Report) – Investment analysts at William Blair decreased their FY2023 earnings estimates for Neumora Therapeutics in a report issued on Monday, November 27th. William Blair analyst M. Minter now forecasts that the company will post earnings of ($4.25) per share for the year, down from their previous estimate of […]Nov 24, 2023 · A high-level overview of Neumora Therapeutics, Inc. (NMRA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. WATERTOWN, Mass., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug ...Neumora Therapeutics Inc. Common Stock stock price (NMRA) NASDAQ: NMRA. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Neumora Therapeutics Inc. Common Stock stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.Neumora Therapeutics, Inc. Common Stock (NMRA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.About Robert Lenz, M.D., Ph.D., executive vice president, head of research and development Dr. Rob Lenz is executive vice president, head of research and development at Neumora.Neumora Therapeutics Inc. Common Stock stock price (NMRA) NASDAQ: NMRA. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Neumora Therapeutics Inc. Common Stock stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.NMRA | Complete Neumora Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.On October 10, 2023, Geoff Meacham, an analyst at Bank of America Securities, commenced coverage on Neumora Therapeutics (NASDAQ:NMRA) by Analyst Coverage and Price Targets for Neumora Therapeutics - Best StocksNeumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for ...Neumora Therapeutics (NASDAQ:NMRA) shares are up over 15% this morning. 10 Top Losers Vivos Therapeutics (NASDAQ: VVOS ) stock is plummeting nearly 34% after a massive rally yesterday on FDA news .

Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) major shareholder Arch Venture Partners Xii, Llc bought 3,357 shares of the company’s stock in a transaction on Tuesday, November 14th.Progressing NMRA-511 and NMRA-266 toward near-term clinical milestones and advancing multiple preclinical neuropsychiatric and neurodegeneration programs. ... Neumora completed its initial public offering of its common stock and shares began trading on the Nasdaq Global Select Market under the ticker symbol “NMRA.” Since its inception ...4 hari yang lalu ... Moleculin Biotech (NASDAQ:MBRX) stock is jumping more than 15% without any clear news today. Neumora Therapeutics (NASDAQ:NMRA) shares are up ...Instagram:https://instagram. sdgr stock forecastdental insurance plans charlotte ncgood dental insurance for bracesaapl stock target price When is Neumora Therapeutics (NASDAQ:NMRA) reporting earnings? A. Neumora Therapeutics ( NMRA) is scheduled to report earnings on February 15, 2024. The last reported earnings were for reported on ... handyman courses for beginnersnovagold stock About Robert Lenz, M.D., Ph.D., executive vice president, head of research and development Dr. Rob Lenz is executive vice president, head of research and development at Neumora. nasdaq sovo Nov 8, 2023 · Within the last quarter, Neumora Therapeutics (NASDAQ:NMRA) has observed the following analyst ratings: According to 6 analyst offering 12-month price targets in the last 3 months, Neumora ... On Wednesday, Neumora Therapeutics Inc. [NASDAQ: NMRA] rose 1.88% to $11.91. The stock’s lowest price that day was $11.76, but it reached a high of $12.14 in the same session. During the last five days, there has been a drop of approximately -0.83%. Over the course of the year, Neumora Therapeutics Inc. shares have dropped approximately -26.71%.